Stop Guessing Where Your NSCLC Asset Stands
Know Exactly Who's Ahead
312 companies racing for a $72B market. Our Enterprise AI transforms trials into actionable intelligence—with full traceability and zero hallucinations.
NSCLC Is Moving Faster Than Most Teams Can Track
828
Active Trials
Phase 1-2
Phase 1-2
312
Competing Sponsors Global
$72B
Market by 2034|Projected
>95%
AI Accuracy | Traceable
The challenges keeping CI teams up at night
1
Your board asks about competitive positioning.
You're piecing together data from 5 different sources—none of them complete.
2
A competitor's Phase 3 readout catches your team off guard—again.
By the time you react, the narrative has shifted.
3
Your analysts spend 80% of their time gathering data and 20% on actual analysis.
The ratio should be flipped.
4
You've tried AI tools.
But hallucinations and untraceable outputs make them unusable for regulatory-grade decisions.
In NSCLC, one missed competitive signal can cost months of development time and millions in repositioning.
What If Your CI Workflow Could Do This?
Here's what happens when Enterprise AI handles the heavy lifting.
Walk into board meetings with complete confidence
AI monitors 828 active NSCLC trials. Get precise positioning for your EGFR, ALK, KRAS G12C, or IO asset, no manual compilation needed.
Anticipate competitor moves before they happen
AI-powered pattern recognition tracks protocol amendments, endpoint changes, and enrollment signals in real-time.
Design trials that payers will actually reimburse
Automated benchmarking against HTA-winning endpoints. Evidence synthesis that takes weeks—delivered in hours.
Trust every insight with full traceability
Every output traces to source—ClinicalTrials.gov, EudraCT, published literature. Zero hallucinations. Audit-ready.
What Biotech Teams Get From Knolens for NSCLC
Teams use Knolens to move from "We think this is the landscape" → "We know exactly where we stand."
Live Competitive Landscape
Never Scramble Before a Board Meeting Again
Clear Competitor Visibility
Know Exactly Who's Targeting Your Patient Population
Faster Internal Alignment
Get CI, Clinical, and BD on the Same Page in Hours
Fewer Strategic Surprises
Spot Threats 3-6 Months Before They Hit
Enterprise AI That Doesn't Hallucinate
Zero Hallucinations
Knowledge graph ensures every insight traces to verified sources
Ultra-Low Compute
Enterprise scale without enterprise cloud costs
AI-Native Workflows
Automates monitoring, alerting, benchmarking, synthesis
Regulatory-Ready
Outputs formatted for HTA submissions and board reporting
Knolens fits naturally into existing workflows.
It avoids adding reporting overhead or requiring teams to learn new systems, serving as the central intelligence layer that connects strategy, development, and commercial functions.
10+ Molecular Subtypes. One AI That Tracks Them All.
Each subtype is its own battlefield—different leaders, endpoints, and payer expectations.
EGFR
ALK
KRAS G12C
RET
MET
HER2
PD-L1 High
BRAF
ROS1
Select your molecular subtype and we'll show you exactly how many competitors are in your space.
See how Knolens tracks NSCLC trials, competitors, and positioning in real time.
Join biotech teams across global organizations making faster, more confident strategic decisions with continuous competitive intelligence.
Global Biotech Trust
Trusted by leading global biotech and pharma teams worldwide.
Indication-Centric Design
Built for indication-focused decision-making, driving clinical and commercial strategy.
Proprietary AI Engine
Powered by Knolens' AI, grounded in regulatory-grade data sources.
Built by Pienomial
Developed by Pienomial, a life sciences tech company for AI-native biotech decision support.
Knolens supports strategic decisions — it doesn't replace scientific judgment or strategic expertise. It amplifies your team's capabilities with comprehensive, current intelligence.
Two Products. One Intelligence Platform.
Live view from the Knolens platform
CI Lens
Know Your Competitive Position—Before It Shifts
- Track every competitor trial & pipeline move automatically
- Catch early signals with AI pattern recognition
- Get automated landscape reports—no manual assembly
- Receive instant alerts on protocol changes
Trial Lens
Design Trials Built to Succeed
- Benchmark endpoints against proven winners
- Analyze patient populations & I/E criteria that work
- Select the right comparators with confidence
- Generate evidence ready for HTA submissions
From Raw Data to Strategic Action
Our AI handles the complexity so you can focus on decisions
Tell Us Your Asset
Share your target, mechanism, and stage. AI configures your competitive view in 24 hours.
Get Your Landscape
Comprehensive intelligence: trial comparisons, endpoint benchmarks, positioning opportunities—all traced to source.
Stay Ahead
Real-time alerts. Monthly AI briefings. Evidence ready for board meetings, payer negotiations, and submissions.
Ready to See Your Competitive Position?
Your competitors are making moves right now. In 15 minutes, you'll know exactly what they are—and how to stay ahead.
"We were preparing for our Phase 3 readout and Knolens flagged that a competitor had quietly amended their protocol to add our same endpoint.
We adjusted our positioning 3 months before their data dropped. That insight alone saved our launch strategy."VP, Competitive Intelligence: Mid-cap Oncology Biotech
Zero
Hallucinations
80%
Less Manual Work
10x
Faster Synthesis
24hr
Setup Time
Get Your NSCLC Competitive Landscape
Get a 15-minute briefing on your specific competitive position.
See how Enterprise AI transforms trial data into strategic intelligence—with full traceability.
Limited to 5 companies per month to ensure personalized attention.